Bristol-Myers Squibb Company (BMY) · page 155 of 197
The slide uses a green arrow to visually quantify the 63% outperformance gap between Amgen and BMY.
Activist deck · precedent_table · cite_precedent · dense density
Slide locked Sign in to view
Slide schematic 6/8
callout 1/2 chart 1/1 metric 0/1 paragraph 1/1 source-note 1/1 title 2/2
2 without position callout 1 · metric 1
calloutmetric · primary
Components 8
primary callout line primary paragraph source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1